| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 284,442 | 272,850 | 265,833 | 281,846 | | Cost of Revenue | (826,038) | 165,803 | 163,719 | 170,293 | | | Gross Profit | 117,448 | 107,047 | 102,114 | 111,553 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (315,841) | 60,989 | 63,857 | 54,590 | | Non Recurring |
-
| 1,713 | (1,713) | (1,636) | | Others | (33,112) | 6,496 | 6,869 | 7,714 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 44,917 | 37,849 | 33,101 | 50,885 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,271) | (1,477) | 5,191 | (11,528) | | Earnings Before Interest And Taxes | 42,646 | 36,372 | 38,292 | 29,897 | | Interest Expense |
-
| (1,314) | 1,314 | (6,490) | | Income Before Tax | 42,646 | 37,686 | 36,978 | 36,387 | | Income Tax Expense | (28,965) | 5,663 | 4,872 | (3,412) | | Minority Interest | 9,620 | (4,048) |
-
| (1,619) | | | | Net Income From Continuing Ops | 81,070 | 27,770 | 31,876 | 46,997 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 33,066 | 27,770 | 31,876 | 46,997 | | Preferred Stock And Other Adjustments |
-
| 1,917 | (1,917) |
-
| | | Net Income Applicable To Common Shares | $33,066 | $29,687 | $29,959 | $46,997 |
|
0.51% Nasdaq 
0.24 (1.60%) 
Income Statement
